|
It was reported that on (b)(6) 2009, the patient underwent the total hip arthroplasty with the liner, the apex hole eliminator, the duraloc, the aml, and the head for the left hip joint at (b)(6) hospital.The surgery was completed successfully without any surgical delay.After the surgery, frequent dislocation occurred, so that the patient visited (b)(6) hospital.On (b)(6) 2022, the patient underwent the revision surgery.The cup, the liner, and the head were removed, and the cup was replaced with zimmer biomet¿s cup.No further information is available.Doi: (b)(6) 2009; dor: (b)(6) 2022; left hip.
|
|
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot: the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
|